A detailed history of Mwa Asset Management transactions in Amgen Inc stock. As of the latest transaction made, Mwa Asset Management holds 2,469 shares of AMGN stock, worth $650,285. This represents 0.53% of its overall portfolio holdings.

Number of Shares
2,469
Previous 2,429 1.65%
Holding current value
$650,285
Previous $759 Million 4.79%
% of portfolio
0.53%
Previous 0.54%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$309.38 - $337.38 $12,375 - $13,495
40 Added 1.65%
2,469 $795 Million
Q2 2024

Jul 26, 2024

BUY
$262.75 - $319.31 $17,604 - $21,393
67 Added 2.84%
2,429 $759 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $39,523 - $47,710
147 Added 6.64%
2,362 $672 Million
Q4 2023

Jan 23, 2024

BUY
$255.7 - $288.46 $15,597 - $17,596
61 Added 2.83%
2,215 $638 Million
Q3 2023

Oct 27, 2023

BUY
$218.65 - $271.46 $470,972 - $584,724
2,154 New
2,154 $579 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mwa Asset Management Portfolio

Follow Mwa Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mwa Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Mwa Asset Management with notifications on news.